Serum beta 2-microglobulin in hepato-biliary diseases.

Area of Science:

• Biochemistry
• Hepatology
• Clinical Diagnostics

Background:

• Serum beta 2-microglobulin (B2M) is a protein found on cell surfaces.
• Elevated B2M levels are associated with various diseases, including cancers and inflammatory conditions.
• Its role in hepato-biliary diseases requires further clarification.

Purpose of the Study:

• To investigate serum B2M levels in patients with hepato-biliary diseases.
• To determine if B2M can differentiate between benign and malignant liver conditions.
• To assess the influence of jaundice and age on B2M levels in liver disease.

Main Methods:

• Serum samples were collected from patients with various hepato-biliary conditions and controls.
• Beta 2-microglobulin levels were measured using standard laboratory assays.
• Statistical analysis was performed to compare B2M levels across different disease groups and with control subjects.

Main Results:

• Serum B2M levels were significantly elevated in both benign and malignant hepato-biliary diseases compared to controls.
• No significant increase in B2M was observed in jaundice caused by acute pancreatitis.
• The age-dependent increase in B2M was present in controls, diminished in malignant liver diseases, and absent in benign liver diseases.
• Jaundice did not influence serum B2M levels.

Conclusions:

• Serum B2M levels are elevated in various hepato-biliary diseases but lack discriminatory power between benign and malignant conditions.
• Serum B2M levels are not a reliable biomarker for diagnosing or differentiating liver diseases.
• Further research may explore other biomarkers for hepato-biliary disease diagnosis.